Dexmedetomidine Protects against Myocardial Ischemia/Reperfusion Injury by Ameliorating Oxidative Stress and Cell Apoptosis through the Trx1-Dependent Akt Pathway
Dexmedetomidine (Dex) was reported to reduce oxidative stress and protect against myocardial Ischemia/Reperfusion (I/R) injury. However, the molecular mechanism involved in its antioxidant property is not fully elucidated. The present study was aimed at investigating whether the Trx1/Akt pathway par...
Main Authors: | Zhi-lin Wu, Jacques Robert Jeppe Davis, Yi Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2020/8979270 |
Similar Items
-
Evolving spectrum of dexmedetomidine preconditioning for Ischemia–reperfusion injury amelioration
by: Jasvinder K Kohli, et al.
Published: (2020-01-01) -
Effects of Dexmedetomidine Postconditioning on Myocardial Ischemia/Reperfusion Injury in Diabetic Rats: Role of the PI3K/Akt-Dependent Signaling Pathway
by: Xiangyang Cheng, et al.
Published: (2018-01-01) -
The Application and Analytical Pathway of Dexmedetomidine in Ischemia/Reperfusion Injury
by: Ying Tang, et al.
Published: (2019-01-01) -
Visnagin ameliorates myocardial ischemia/reperfusion injury through the promotion of autophagy and the inhibition of apoptosis
by: Hai-rong Fu, et al.
Published: (2020-09-01) -
Therapeutic effect of dexmedetomidine on myocardial ischemia reperfusion injury in type 2 diabetic rat model under P13K/Akt pathway
by: Yapeng Guo, et al.
Published: (2020-07-01)